title: APP+, a fluorescent analogue of the neurotoxin MPP+, is a marker of catecholamine neurons in brain tissue, but not a fluorescent false neurotransmitter.
abstract: We have previously introduced fluorescent false neurotransmitters (FFNs) as optical reporters that enable visualization of individual dopaminergic presynaptic terminals and their activity in the brain. In this context, we examined the fluorescent pyridinium dye 4-(4-dimethylamino)phenyl-1-methylpyridinium (APP+), a fluorescent analogue of the dopaminergic neurotoxin MPP+, in acute mouse brain tissue. APP+ is a substrate for the dopamine transporter (DAT), norepinephrine transporter (NET), and serotonin transporter (SERT), and as such represented a candidate for the development of new FFN probes. Here we report that APP+ labels cell bodies of catecholaminergic neurons in the midbrain in a DAT- and NET-dependent manner, as well as fine dopaminergic axonal processes in the dorsal striatum. APP+ destaining from presynaptic terminals in the dorsal striatum was also examined under the conditions inducing depolarization and exocytotic neurotransmitter release. Application of KCl led to a small but significant degree of destaining (approximately 15% compared to control), which stands in contrast to a nearly complete destaining of the new generation FFN agent, FFN102. Electrical stimulation of brain slices at 10 Hz afforded no significant change in the APP+ signal. These results indicate that the majority of the APP+ signal in axonal processes originates from labeled organelles including mitochondria, whereas only a minor component of the APP+ signal represents the releasable synaptic vesicular pool. These results also show that APP+ may serve as a useful probe for identifying catecholaminergic innervations in the brain, although it is a poor candidate for the development of FFNs.
authors: Department of Chemistry, Columbia University , 3000 Broadway, New York, New York 10027, United States.
authors: Richard J
authors: RJ
authors: Karpowicz
authors: Matthew
authors: M
authors: Dunn
authors: David
authors: D
authors: Sulzer
authors: Dalibor
authors: D
authors: Sames
mesh_terms: D015655:1-Methyl-4-phenylpyridinium / Q000031:analogs & derivatives*; D059331:Adrenergic Neurons / Q000378:metabolism*; D000814:Aniline Compounds / Q000378:metabolism*; D000818:Animals; D001369:Axons / Q000378:metabolism; D001921:Brain / Q000378:metabolism*; D050483:Dopamine Plasma Membrane Transport Proteins / Q000378:metabolism; D059290:Dopaminergic Neurons / Q000378:metabolism*; D005456:Fluorescent Dyes / Q000378:metabolism*; D051379:Mice; D008928:Mitochondria / Q000378:metabolism; D017072:Neostriatum / Q000378:metabolism; D050484:Norepinephrine Plasma Membrane Transport Proteins / Q000378:metabolism; D017729:Presynaptic Terminals / Q000378:metabolism; D011726:Pyridinium Compounds / Q000378:metabolism*; D013569:Synapses / Q000378:metabolism; D013572:Synaptic Vesicles / Q000378:metabolism
chemical_list: C572632:4-(4-(dimethylamino)phenyl)-1-methylpyridinium; D000814:Aniline Compounds; D050483:Dopamine Plasma Membrane Transport Proteins; D005456:Fluorescent Dyes; D050484:Norepinephrine Plasma Membrane Transport Proteins; D011726:Pyridinium Compounds; C493228:Slc6a2 protein, mouse; C493215:Slc6a3 protein, mouse; D015655:1-Methyl-4-phenylpyridinium
references: Mol Biosyst. 2009 May;5(5):411-21
references: 19381357
references: Biochem Pharmacol. 2007 Apr 15;73(8):1225-36
references: 17316571
references: Proc Natl Acad Sci U S A. 1985 Apr;82(7):2173-7
references: 3872460
references: Trends Neurosci. 2007 Feb;30(2):62-9
references: 17173981
references: Br J Pharmacol. 2010 Feb;159(4):797-807
references: 20136837
references: Biotechniques. 2012 Nov;53(5):305-9
references: 23570046
references: Proc Natl Acad Sci U S A. 2013 Jan 15;110(3):870-5
references: 23277566
references: J Neurosci Methods. 2012 Aug 15;209(2):357-66
references: 22698664
references: Cell. 1992 Aug 21;70(4):539-51
references: 1505023
references: J Neurosci. 2012 Jun 27;32(26):8919-29
references: 22745492
references: Nat Methods. 2004 Oct;1(1):31-7
references: 15782150
references: Methods Mol Biol. 2011;793:363-76
references: 21913113
references: J Biol Chem. 2005 May 13;280(19):19177-84
references: 15757904
references: J Biol Chem. 1998 Dec 4;273(49):32776-86
references: 9830022
references: Neuron. 2011 Jan 13;69(1):9-21
references: 21220095
references: J Neurochem. 1997 Sep;69(3):1322-5
references: 9282960
references: Proc Natl Acad Sci U S A. 1994 Dec 20;91(26):12584-8
references: 7809082
references: CNS Neurol Disord Drug Targets. 2006 Feb;5(1):45-56
references: 16613553
references: J Neurosci Methods. 2008 Mar 30;169(1):168-76
references: 18222006
references: J Biol Chem. 1989 Aug 5;264(22):12859-66
references: 2473983
references: Nat Rev Neurosci. 2004 Jun;5(6):483-94
references: 15152198
references: Biochim Biophys Acta. 1976 Jan 15;423(1):1-14
references: 764877
references: Eur J Pharmacol. 1985 Dec 17;119(3):247-50
references: 3879221
references: FEBS Lett. 1995 Dec 18;377(2):201-7
references: 8543051
references: Biophys J. 2008 Oct;95(8):4068-76
references: 18641060
references: ACS Chem Neurosci. 2013 Jan 16;4(1):161-70
references: 23336055
references: ACS Chem Neurosci. 2013 May 15;4(5):648-51
references: 23862751
references: J Biol Chem. 2003 Mar 14;278(11):9768-77
references: 12499385
references: Drugs. 1979 Jul;18(1):1-24
references: 477572
references: Biochemistry. 1980 May 27;19(11):2396-404
references: 6770893
references: J Pharmacol Exp Ther. 2000 May;293(2):336-42
references: 10773000
references: Org Biomol Chem. 2011 Apr 7;9(7):2142-8
references: 21293810
references: Science. 2009 Jun 12;324(5933):1441-4
references: 19423778
references: Proc Natl Acad Sci U S A. 2009 Dec 22;106(51):21960-5
references: 20007370
references: J Biol Chem. 2012 Mar 16;287(12):8852-63
references: 22291010
references: Mikrobiol Zh. 1962;24(3):23-8
references: 14458073
references: Toxicology. 1988 Apr;49(1):17-23
references: 3287690
references: J Neurosci. 1996 Jul 1;16(13):4135-45
references: 8753875
references: Nat Protoc. 2006;1(6):2916-21
references: 17406552
references: J Pharmacol Exp Ther. 2010 Dec;335(3):743-53
references: 20858707
references: J Neurosci. 1992 Feb;12(2):363-75
references: 1371312
references: Psychiatry Res. 1979 Dec;1(3):249-54
references: 298352
references: Neuron. 2004 May 27;42(4):653-63
references: 15157425
references: Neuroscience. 2005;130(1):107-17
references: 15561429
references: Synapse. 1997 Jun;26(2):194-8
references: 9131778
references: J Neurochem. 2002 Jul;82(2):295-304
references: 12124430
references: Am J Physiol Cell Physiol. 2008 Apr;294(4):C1004-11
references: 18287335
references: Mol Pharmacol. 1995 Mar;47(3):544-50
references: 7700252
references: J Microsc. 1993 Mar;169(3):375-382
references: 33930978